EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Inflammatory chemokine ( C‐C motif) ligand 8 inhibition ameliorates peritoneal fibrosis

Yeonhee Lee iD, Jangwook Lee, Minkyoung Park, Areum Seo, Kyu Hyeon Kim, Seonmi Kim, Minjung Kang, Eunjeong Kang, Kyung Don Yoo, Sunhwa Lee, Dong Ki Kim, Kook-Hwan Oh und 3 weitere

The FASEB Journal · 2023

DOI: 10.1096/fj.202200784r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2023. Verfasst von Yeonhee Lee und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Uijeongbu Eulji Medical Center, Eulji University, Gyeonggi-do, Republic of Korea. Hauptthemen laut MEDLINE: Peritoneal Fibrosis, Peritonitis. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Peritoneal fibrosis (PF) is an irreversible complication of peritoneal dialysis (PD) that leads to loss of peritoneal membrane function. We investigated PD effluent and serum levels and the tissue expression of chemokine (C‐C motif) ligand 8 (CCL8) in patients with PD. Additionally, we investigated their association with PF in a mouse model. Eighty‐two end‐stage renal disease (ESRD) patients with PD were examined. CCL8 levels were measured via enzyme‐linked immunosorbent assays in PD effluents and serum and analyzed with peritoneal transport parameters. Human peritoneal mesothelial cells (hPMCs) were obtained from the PD effluents of 20 patients. Primary cultured hPMCs were treated with recombinant (r) transforming growth factor (TGF)‐β, and CCL8 expression was assessed via western blotting. As the duration of PD increased, the concentration of CCL8 in PD effluents significantly increased. Correlations between peritoneal transport parameters and dialysate CCL8 levels were observed. Western blotting analysis showed that CCL8 was upregulated via rTGF‐β treatment, accompanied by increases in markers of inflammation, fibrosis, senescence, and apoptosis in hPMCs after induction of fibrosis with rTGF‐β. Anti‐CCL8 monoclonal antibody (mAb) treatment suppressed the rTGF‐β‐induced increase in all analyzed markers. Immunohistochemical analysis revealed that CCL8 along with fibrosis‐ and inflammation‐related markers were significantly increased in the PF mouse model. Functional blockade of CCL8 using a CCR8 inhibitor (R243) abrogated peritoneal inflammation and fibrosis in vivo. In conclusion, high CCL8 levels in PD effluents may be associated with an increased risk of PD failure, and the CCL8 pathway is associated with PF. CCL8 blockade can ameliorate peritoneal inflammation and fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peritoneal FibrosisPeritonitisAnimalsMiceHumansChemokine CCL8PeritoneumChemokinesLigandsInflammationDisease Models, Animal

Stichwörter der Autor:innen

apoptosischemokine (C-C motif) ligand 8 (CCL8)fibrosisinflammationperitoneal dialysis

Substanzen

Chemokine CCL8ChemokinesLigands

Autor:innen und Institutionen

  • Department of Internal Medicine, Uijeongbu Eulji Medical Center, Eulji University, Gyeonggi-do, Republic of Korea.
  • Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Department of Internal Medicine, Dongguk University Ilsan Hospital, Gyeonggi-do, Republic of Korea.
  • Kidney Research Institute, Seoul National University, Seoul, Republic of Korea.
  • Department of Internal Medicine, Ewha Womans University Seoul Hospital, Ewha Womans University College of Medicine, Seoul, Republic of Korea.
  • Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea.

ORCID-Profile: Yeonhee Lee, Kwon Wook Joo, Seung Hee Yang

Zitieren

APA

Lee, Y., Lee, J., Park, M., Seo, A., Kim, K. H., Kim, S., Kang, M., Kang, E., Yoo, K. D., Lee, S., Kim, D. K., Oh, K. H., Kim, Y. S., Joo, K. W., & Yang, S. H. (2023). Inflammatory chemokine ( C‐C motif) ligand 8 inhibition ameliorates peritoneal fibrosis. The FASEB Journal. https://doi.org/10.1096/fj.202200784r

Vancouver

Lee Y, Lee J, Park M, Seo A, Kim KH, Kim S, et al. Inflammatory chemokine ( C‐C motif) ligand 8 inhibition ameliorates peritoneal fibrosis. The FASEB Journal. 2023. doi:10.1096/fj.202200784r

BibTeX
@article{Lee2023,
  author = {Lee, Yeonhee and Lee, Jangwook and Park, Minkyoung and Seo, Areum and Kim, Kyu Hyeon and Kim, Seonmi and Kang, Minjung and Kang, Eunjeong and Yoo, Kyung Don and Lee, Sunhwa and Kim, Dong Ki and Oh, Kook-Hwan and Kim, Yon Su and Joo, Kwon Wook and Yang, Seung Hee},
  title = {Inflammatory chemokine ( C‐C motif) ligand 8 inhibition ameliorates peritoneal fibrosis},
  journal = {The FASEB Journal},
  year = {2023},
  doi = {10.1096/fj.202200784r}
}
Kostenlos starten →